XT

XVir Therapeutics

Germany - Munich
Biotechnology
WebsiteLinkedInCareers Page

Focus: YB-1 dependent oncolytic adenoviruses for oncolytic immunotherapy

XVir Therapeutics is a life sciences company focused on YB-1 dependent oncolytic adenoviruses for oncolytic immunotherapy.

Open Jobs
0

Open Jobs (0)

No open positions listed yet. Check their careers page directly.